Voyageur Pharmaceuticals (CVE:VM) Sets New 12-Month High – Here’s What Happened
by Teresa Graham · The Cerbat GemVoyageur Pharmaceuticals Ltd. (CVE:VM – Get Free Report) reached a new 52-week high during mid-day trading on Friday . The stock traded as high as C$0.11 and last traded at C$0.11, with a volume of 641138 shares trading hands. The stock had previously closed at C$0.09.
Voyageur Pharmaceuticals Stock Up 16.7 %
The company has a debt-to-equity ratio of 3.21, a current ratio of 0.17 and a quick ratio of 0.84. The stock has a 50 day moving average price of C$0.07 and a 200-day moving average price of C$0.06. The stock has a market capitalization of C$14.64 million, a P/E ratio of -10.50 and a beta of 0.32.
About Voyageur Pharmaceuticals
Voyageur Pharmaceuticals Ltd., together with its subsidiaries, engages in the acquiring, exploring, and developing raw materials for pharmaceutical products, primarily in the province of British Columbia, Canada, and the state of Utah. The company develops barium and iodine-based APIs. The company was formerly known as Voyageur Minerals Ltd.
Read More
- Five stocks we like better than Voyageur Pharmaceuticals
- Roth IRA Calculator: Calculate Your Potential Returns
- Opal Fuels CEO on Steering the Future of Renewable Natural Gas
- Want to Profit on the Downtrend? Downtrends, Explained.
- MicroStrategy Joins Nasdaq-100: 2 Crypto Stocks Set to Win
- The Top 3 Healthcare Dividend Stocks to Buy and Hold
- 2 Underrated Quantum Computing Companies Starting to Rally